SCHEMBL29990010

SCHEMBL29990010

CC(C)(C)[S@@+]([O-])/N=C/c1ccc(Cl)c(C(F)(F)F)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30798661 1.00
SCHEMBL30798747 0.84
SCHEMBL29989538 0.84
SCHEMBL29005134 0.84
SCHEMBL30342106 0.84
SCHEMBL29005275 0.80
SCHEMBL30342111 0.80
SCHEMBL30342195 0.77 GLP1R (0.33)
SCHEMBL29005207 0.77 GLP1R (0.33)
SCHEMBL16971736 0.74 NFE2L2 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4334306-A1 ARYL 3-OXOPIPERAZINE CARBOXAMIDES AND HETEROARYL 3-OXOPIPERAZINE CARBOXAMIDES AS NAV1.8 INHIBITORS Merck Sharp & Dohme LLC (US) 2024-03-13 EP disclosed
WO-2022235558-A1 ARYL 3-OXOPIPERAZINE CARBOXAMIDES AND HETEROARYL 3-OXOPIPERAZINE CARBOXAMIDES AS NAV1.8 INHIBITORS MERCK SHARP & DOHME LLC (US) 2022-11-10 WO disclosed